STOCK TITAN

Taylor Devices Inc SEC Filings

TAYD NASDAQ

Welcome to our dedicated page for Taylor Devices SEC filings (Ticker: TAYD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Taylor Devices, Inc. (TAYD) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Taylor Devices is a manufacturing company that designs, develops, manufactures and markets shock absorption, rate control and energy storage devices for vehicles, machinery, equipment and structures, and its filings offer detailed insight into this business.

Investors can use this page to locate annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which typically contain information about Taylor Devices’ markets in Aerospace/Defense, Structural Construction and Industrial segments, along with discussions of sales trends, order backlog and risk factors. Current reports on Form 8‑K, such as the October 2025 filing describing shareholder approval of the 2025 Stock Option Plan and other annual meeting outcomes, document material events including equity compensation plans, auditor ratification and voting results.

The page also surfaces proxy statements (DEF 14A), where Taylor Devices outlines governance matters like its classified board structure, director elections and proposals such as the Taylor Devices, Inc. 2025 Stock Option Plan. These documents provide context on how the company’s board oversees strategy and compensation.

Stock Titan enhances these filings with AI‑powered summaries that explain key points in plain language, helping users quickly understand lengthy documents without reading every page. Real‑time updates from EDGAR ensure that new 10‑K, 10‑Q, 8‑K and proxy filings appear promptly, and insider‑related forms such as Form 4 can be reviewed to monitor transactions by directors and officers. This makes the TAYD filings page a practical starting point for analyzing Taylor Devices’ regulatory history and ongoing disclosure practices.

Rhea-AI Summary

Wax Asset Management, LLC filed an amended ownership report showing it beneficially owns 297,666 shares of Taylor Devices Inc common stock, representing 9.4% of the outstanding class as of 12/31/2025. Wax Asset Management has sole power to vote and dispose of all these shares.

The firm states the shares were acquired and are held in the ordinary course of business, and not with the purpose or effect of changing or influencing control of Taylor Devices. The position is not held on behalf of other parties and is not part of any reported group.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Taylor Devices, Inc. director F. Eric Armenat reported selling his remaining common shares over two days. On January 22, 2026, he sold 2,800 shares of common stock at a price of $71.773 per share. On January 23, 2026, he executed three additional sales of 528 shares at $72.103 per share, 300 shares at $71.19 per share, and 700 shares at $72.85 per share. Following the final transaction, the Form 4 shows he directly owns 0 shares of Taylor Devices common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Taylor Devices, Inc. director F. Eric Armenat reported an option exercise and related share withholding on 01/21/2026. He exercised a stock option for 5,000 shares of common stock at a price of $9.85 per share, increasing his direct common stock holdings to 5,000 shares immediately after the exercise.

In a separate transaction coded “F” the same day, 672 of those shares were withheld at a value of $73.283 per share, typically reflecting shares surrendered to cover taxes. After these transactions, Armenat directly owned 4,328 shares of Taylor Devices common stock, and the reported 5,000-share stock option position was reduced to zero.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Taylor Devices director F. Eric Armenat reported selling his remaining common shares of the company. The Form 4 shows open-market sales on January 14, 2026 totaling 4,120 shares of Taylor Devices, Inc. common stock.

The first transaction was a sale of 3,820 shares at a weighted average price of $73.21 per share, with individual trade prices ranging from $72.65 to $73.57. A second sale of 300 shares at $74.00 per share is also reported. Following these transactions, Armenat reports 0 shares of Taylor Devices common stock held with direct ownership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Taylor Devices director F. Eric Armenat reported an option exercise and related share withholding. On January 9, 2026, he exercised a stock option for 5,000 shares of common stock at an exercise price of $11.975 per share, converting a "Stock Option (Right to Buy)" into common stock and reducing his beneficially owned derivative securities to zero. On the same date, 880 shares of common stock were disposed of in a transaction coded "F" at $68.061 per share, reflecting shares withheld to cover obligations associated with the option exercise. After these transactions, he directly owned 4,120 shares of Taylor Devices common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Taylor Devices, Inc. (TAYD) filed a Form S-8 to register 290,000 shares of common stock, par value $0.025 per share, for issuance under the Taylor Devices, Inc. 2025 Stock Option Plan.

The filing incorporates by reference the company’s Form 10-K for the year ended May 31, 2025 and related Exchange Act reports. Legal matters are addressed by Hodgson Russ LLP.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
Rhea-AI Summary

Taylor Devices, Inc. (TAYD) reported the results of its October 17, 2025 annual meeting. Shareholders approved the 2025 Stock Option Plan, elected Robert Carey as a Class 3 Director for a term expiring in 2028, and ratified Lumsden & McCormick, LLP as the independent registered public accounting firm for the fiscal year ending May 31, 2026.

Vote results: Director election—Votes For: 1,061,147; Votes Withheld: 434,104; Broker Non-Votes: 686,497. Auditor ratification—Votes For: 2,174,614; Votes Against: 896; Votes Abstained: 6,238. 2025 Stock Option Plan—Votes For: 1,343,996; Votes Against: 147,376; Votes Abstained: 3,879; Broker Non-Votes: 686,497.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Taylor Devices, Inc. reported lower results for the quarter ended August 31, 2025. Net sales were about $9.9 million, down from roughly $11.6 million a year earlier, mainly from weaker long-term project activity and a sharp drop in Asia sales. Net income was $2.19 million, compared with $2.67 million, and earnings per share fell to $0.70 from $0.85 as gross margin slipped to 45% from 47%.

The company remains debt-free with a strong balance sheet, holding $2.2 million in cash and $34.2 million in short-term investments, and total stockholders’ equity of $64.3 million. Backlog was $27.9 million on 127 open orders, slightly below the $28.4 million level a year earlier but above the prior year-end. Operating cash flow turned positive at $0.5 million, and the company plans about $2.75 million in capital spending over the next twelve months while not providing for dividends or profit sharing this fiscal year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.14%
Tags
quarterly report
-
Rhea-AI Summary

Taylor Devices, Inc. has called its 2025 annual shareholder meeting for October 17, 2025, with one Class 3 director, Robert M. Carey, standing for election to a three-year term. Shareholders will also vote on ratifying Lumsden & McCormick, LLP as auditor for the fiscal year ending May 31, 2026.

A key proposal is approval of the 2025 Taylor Devices, Inc. Stock Option Plan, which would reserve up to 316,200 shares for equity awards and replace the 2022 plan. As of May 31, 2025, stock options outstanding totaled 399,300, and fully diluted overhang was about 11.9%, which would rise to roughly 18.5% if the new plan is approved. The proxy details board composition, committee activity, director and executive compensation, and insider trading and governance policies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
Rhea-AI Summary

Taylor Devices, Inc. (TAYD) — Annual report excerpts The filing excerpts describe audit procedures over estimates and revenue recognition, inventory testing and physical observation, and inventory valuation methods. The company reported inventory disposals of $107,000 and $791,000 for the years ended May 31, 2025 and 2024, respectively. The provision for potential inventory obsolescence was $0 in 2025 and $386,000 in 2024. Accounts payable included amounts of $97,673 and $372,347 as of May 31, 2025 and 2024. The filing notes common shares issued to employees: 155 shares (price range $32.51–$49.40) and 372 shares (price range $21.70–$48.89), and 215,838 shares reserved for future issue as of May 31, 2025. The company continues reworking slow-moving inventory to fulfill customer orders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.82%
Tags
annual report

FAQ

What is the current stock price of Taylor Devices (TAYD)?

The current stock price of Taylor Devices (TAYD) is $87.74 as of February 27, 2026.

What is the market cap of Taylor Devices (TAYD)?

The market cap of Taylor Devices (TAYD) is approximately 265.4M.

TAYD Rankings

TAYD Stock Data

265.40M
3.07M
Specialty Industrial Machinery
General Industrial Machinery & Equipment, Nec
Link
United States
NORTH TONAWANDA

TAYD RSS Feed